LOS ANGELES, CALIFORNIA - JUNE 12, 2023 - Now in its seventh year, the CTIP Catalyzing Pediatric Innovation Grant remains competitive. CTIP received numerous Letters of Intent for our 2023 Catalyzing Pediatric Innovation Grant and is excited to share the many innovative products and concepts submitted for application in the pediatric medical device space.
By the numbers: Applications from 25 states, including 36% of applications from California across 18 different pediatric subspecialties
All device classes:
CTIP is committed to diversity, equity, and inclusion. We believe in supporting individuals from diverse and historically underrepresented backgrounds in the fields of science, technology, engineering, and business. In their application, members of the company’s founding or executive team (for example: CEO, COO, CFO) identified as:
The 2023 finalists, announced June 12, 2023 are as follows:
The Prone Positioner is a device to allow babies with certain complex medical conditions to participate in safe and comfortable "tummy time", which is an important aspect of development.
Bloom Standard's EVA device is the first self-driving, autonomous ultrasound screening device specifically designed for infant and pediatric use.
Boppli is designed to be a wearable, non-invasive, wireless blood pressure monitor for fragile neonatal infants in the NICU; it is designed to be easier to use than a standard blood pressure cuff and safer than an arterial line (FDA clearance pending).
The Endoscope Converter is an add-on disposable assembly that can convert a neonatal endoscope into a neonatal duodenoscope.
TheraB’s solution is the SnugLit, an innovative device that delivers blue light phototherapy in a battery-powered, wearable, and portable swaddle garment that completely eliminates separation between mom and baby while treating neonatal jaundice.
LX002 is a self-guided cognitive behavioral therapy (CBT)-based digital therapeutic for adolescents with symptoms of anxiety.
The Percutaneous Solutions for Redirecting Blood Flow in Patients with Congenital Heart Disease is a device that leverages the current Renata growth stent technology in a new application aimed to redirect blood flow in children suffering from congenital heart disease and will serve as a lifelong alternative to multiple open heart surgeries.
LinkedIn: Renata Medical
The Pressure-Targeted High Flow Therapy in Premature Babies Using a Multifunctional Orogastric Feeding Tube aims to revolutionize newborn respiratory support by non-invasively and continuously measuring pressure inside the chest, combining the comfort of high-flow nasal cannula (HFNC) with the consistent distending pressure of continuous positive airway pressure (CPAP).
Facebook: Dell Medical School - UT Austin Instagram: @dellmedschool LinkedIn: Dell Medical School at the University of Texas at Austin Twitter: @DellMedSchool
The Close and Comfortable: 1.5T Flexible Pediatric MR Body Array is a dramatically faster, more accurate, and more comfortable Pediatric MR Body Array for 1.5T scanners to get closer to all patients.
FlowSense Usability Study in Support of FDA Approval is an FDA breakthrough designated diagnostic wearable solution for hydrocephalus that can detect cerebrospinal fluid flow bedside in minutes without wires, needles, capital equipment, or radiation.
AtriaLock is the first Atrial Septal Defect Occluder designed for future left atrium access, ensuring patients have the maximum flexibility in treatment options should future procedures be necessary.
Stark Street Materials is developing a novel thyroid shield to increase radiation protection for pediatric patients during dental X-ray imaging.
LinkedIn: Stark Street Materials
Contact us at email@example.com